A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3 - PubMed (original) (raw)
. 2005 Jan 28;280(4):2972-80.
doi: 10.1074/jbc.M411323200. Epub 2004 Nov 10.
Patrick Chames, Roman C Hillig, Robyn L Stanfield, Gerhard Held, Pierre G Coulie, Claudia Alings, Gabriele Wille, Wolfram Saenger, Barbara Uchanska-Ziegler, Hennie R Hoogenboom, Andreas Ziegler
Affiliations
- PMID: 15537658
- DOI: 10.1074/jbc.M411323200
Free article
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3
Martin Hülsmeyer et al. J Biol Chem. 2005.
Free article
Abstract
Antibodies with T cell receptor-like specificity possess a considerable diagnostic and therapeutic potential, but the structural basis of the interaction between an antibody and an histocompatibility antigen has so far not been determined. We present here the crystal structure (at 2.15 A resolution) of the recombinant, affinity-matured human antibody fragment Fab-Hyb3 bound to the tumor-associated human leukocyte antigen (HLA)/peptide complex HLA-A1.MAGE-A1. Fab-Hyb3 employs a diagonal docking mode resembling that of T cell receptors. However, other than these natural ligands, the antibody uses only four of its six complementarity-determining regions for direct interactions with the target. It recognizes the C-terminal half of the MAGE-A1 peptide, the HLA-A1 alpha1-helix, and N-terminal residues of the alpha2-helix, accompanied by a large tilting angle between the two types of molecules within the complex. Interestingly, only a single hydrogen bond between a peptide side chain and Fab-Hyb3 contributes to the interaction, but large buried surface areas with pronounced shape complementarity assure high affinity and specificity for MAGE-A1. The HLA-A1.MAGE-A1.antibody structure is discussed in comparison with those of natural ligands recognizing HLA.peptide complexes.
Similar articles
- Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.
Kumar P, Vahedi-Faridi A, Saenger W, Ziegler A, Uchanska-Ziegler B. Kumar P, et al. Protein Sci. 2009 Jan;18(1):37-49. doi: 10.1002/pro.4. Protein Sci. 2009. PMID: 19177349 Free PMC article. - Monoclonal and recombinant antibodies with T cell receptor-like reactivity.
Ziegler A, Coulie PG, Uchańska-Ziegler B. Ziegler A, et al. Recent Results Cancer Res. 2007;176:229-41. doi: 10.1007/978-3-540-46091-6_20. Recent Results Cancer Res. 2007. PMID: 17607930 - How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide.
Mareeva T, Martinez-Hackert E, Sykulev Y. Mareeva T, et al. J Biol Chem. 2008 Oct 24;283(43):29053-9. doi: 10.1074/jbc.M804996200. Epub 2008 Aug 14. J Biol Chem. 2008. PMID: 18703505 Free PMC article. - Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC, Shan L, Goldsteen BZ, Guddat LW, Thakur A, Landolfi NF, Co MS, Vasquez M, Queen C, Ramsland PA, Edmundson AB. Fan ZC, et al. J Mol Recognit. 1999 Jan-Feb;12(1):19-32. doi: 10.1002/(SICI)1099-1352(199901/02)12:1<19::AID-JMR445>3.0.CO;2-Y. J Mol Recognit. 1999. PMID: 10398393 Review. - Structure, function and properties of antibody binding sites.
Mian IS, Bradwell AR, Olson AJ. Mian IS, et al. J Mol Biol. 1991 Jan 5;217(1):133-51. doi: 10.1016/0022-2836(91)90617-f. J Mol Biol. 1991. PMID: 1988675 Review.
Cited by
- Experimental Structures of Antibody/MHC-I Complexes Reveal Details of Epitopes Overlooked by Computational Prediction.
Boyd LF, Jiang J, Ahmad J, Natarajan K, Margulies DH. Boyd LF, et al. J Immunol. 2024 Apr 15;212(8):1366-1380. doi: 10.4049/jimmunol.2300839. J Immunol. 2024. PMID: 38456672 Free PMC article. - Experimental structures of antibody/MHC-I complexes reveal details of epitopes overlooked by computational prediction.
Boyd LF, Jiang J, Ahmad J, Natarajan K, Margulies DH. Boyd LF, et al. bioRxiv [Preprint]. 2023 Dec 4:2023.12.01.569627. doi: 10.1101/2023.12.01.569627. bioRxiv. 2023. PMID: 38106040 Free PMC article. Updated. Preprint. - Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity.
Mariuzza RA, Wu D, Pierce BG. Mariuzza RA, et al. Front Immunol. 2023 Nov 17;14:1303304. doi: 10.3389/fimmu.2023.1303304. eCollection 2023. Front Immunol. 2023. PMID: 38045695 Free PMC article. Review. - Challenges and solutions for therapeutic TCR-based agents.
Malviya M, Aretz ZEH, Molvi Z, Lee J, Pierre S, Wallisch P, Dao T, Scheinberg DA. Malviya M, et al. Immunol Rev. 2023 Nov;320(1):58-82. doi: 10.1111/imr.13233. Epub 2023 Jul 16. Immunol Rev. 2023. PMID: 37455333 Review. - Computationally profiling peptide:MHC recognition by T-cell receptors and T-cell receptor-mimetic antibodies.
Raybould MIJ, Nissley DA, Kumar S, Deane CM. Raybould MIJ, et al. Front Immunol. 2023 Jan 9;13:1080596. doi: 10.3389/fimmu.2022.1080596. eCollection 2022. Front Immunol. 2023. PMID: 36700202 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials